WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNA interference (RNAi) based therapeutics, today announced that it will host its first R&D webcast to review the company’s strategy, technology, and expanding pipeline of innovative RNAi therapies. The R&D webcast will take place on Monday, December 15 at 4:30 p.m. To register, please visit www.dicerna.com.
Help employers find you! Check out all the jobs and post your resume.
